Flizasertib

N/A

Report date: 2025/03/12 08:55:11
NME

Base Information

Drug NameFlizasertib
Drug Alias NameRG-6287RO-7288817GDC-8264
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein-serine-threonine kinases inhibitors
TargetsProtein-serine-threonine kinases
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGenentech Inc
China Registration ClassN/A

Develop Information

Active CompaniesGenentech Inc
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A